These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Cluster size variability and imbalance in cluster randomized controlled trials. Carter B Stat Med; 2010 Dec; 29(29):2984-93. PubMed ID: 20963749 [TBL] [Abstract][Full Text] [Related]
5. Comparing completely and stratified randomized designs in cluster randomized trials when the stratifying factor is cluster size: a simulation study. Lewsey JD Stat Med; 2004 Mar; 23(6):897-905. PubMed ID: 15027079 [TBL] [Abstract][Full Text] [Related]
9. Efficient design of cluster randomized and multicentre trials with unknown intraclass correlation. van Breukelen GJ; Candel MJ Stat Methods Med Res; 2015 Oct; 24(5):540-56. PubMed ID: 21937473 [TBL] [Abstract][Full Text] [Related]
10. The effect of heterogeneous variance on efficiency and power of cluster randomized trials with a balanced 2 × 2 factorial design. Lemme F; van Breukelen GJ; Candel MJ; Berger MP Stat Methods Med Res; 2015 Oct; 24(5):574-93. PubMed ID: 25911332 [TBL] [Abstract][Full Text] [Related]
11. Relative efficiency and sample size for cluster randomized trials with variable cluster sizes. You Z; Williams OD; Aban I; Kabagambe EK; Tiwari HK; Cutter G Clin Trials; 2011 Feb; 8(1):27-36. PubMed ID: 21163852 [TBL] [Abstract][Full Text] [Related]
13. The effect of cluster size variability on statistical power in cluster-randomized trials. Lauer SA; Kleinman KP; Reich NG PLoS One; 2015; 10(4):e0119074. PubMed ID: 25830416 [TBL] [Abstract][Full Text] [Related]
14. Pitfalls of and controversies in cluster randomization trials. Donner A; Klar N Am J Public Health; 2004 Mar; 94(3):416-22. PubMed ID: 14998805 [TBL] [Abstract][Full Text] [Related]
15. Power and sample size requirements for GEE analyses of cluster randomized crossover trials. Li F; Forbes AB; Turner EL; Preisser JS Stat Med; 2019 Feb; 38(4):636-649. PubMed ID: 30298551 [TBL] [Abstract][Full Text] [Related]
16. Efficient ways exist to obtain the optimal sample size in clinical trials in rare diseases. van der Lee JH; Wesseling J; Tanck MW; Offringa M J Clin Epidemiol; 2008 Apr; 61(4):324-30. PubMed ID: 18313556 [TBL] [Abstract][Full Text] [Related]
17. Reliability, effect size, and responsiveness of health status measures in the design of randomized and cluster-randomized trials. Diehr P; Chen L; Patrick D; Feng Z; Yasui Y Contemp Clin Trials; 2005 Feb; 26(1):45-58. PubMed ID: 15837452 [TBL] [Abstract][Full Text] [Related]
18. Design, analysis and presentation of factorial randomised controlled trials. Montgomery AA; Peters TJ; Little P BMC Med Res Methodol; 2003 Nov; 3():26. PubMed ID: 14633287 [TBL] [Abstract][Full Text] [Related]